Indeed, PDL‐1 testing of collected tissue specimens may often be unworkable, primarily because tissue biopsies from advanced cancer patients, including those from non‐small cell lung cancer (NSCLC), are highly challenging if not impossible to obtain. The gene discussed is CD274; the disease is non-small cell lung carcinoma.